1-3 of 3
Kyle Runckel, BS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting XIAP Via Degradation of MDM-2 By MX69 in Aggressive Lymphomas

Sumera Khan, MSc, MD, Kyle Runckel, BS, Cory Mavis, BSc, MSc, Matthew J. Barth, MD, Francisco J. Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5379.
https://doi.org/10.1182/blood-2018-99-118480
Published: 2018
Journal Articles

XIAP Knockdown Can Increase the Activity of Caspase 3 and 7, and Restore the Apoptotic Response in Cell Line Models of Rituximab Relapse/Refractory B-Cell Lymphoma

Kyle Runckel, BS, Cory Mavis, BSc, MSc, Francisco J. Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1478.
https://doi.org/10.1182/blood.V130.Suppl_1.1478.1478
Published: 2017
Journal Articles

The SMAC Mimetic Lcl-161 Demonstrates Anti-Tumor Activity As a Single Agent and Decreases the Apoptotic Threshold of Chemotherapy Agents in Rituximab-Chemotherapy Sensitive and Resistant Lymphoma Pre-Clinical Models

Kyle Runckel, BS, Cory Mavis, BSc, MSc, Joseph Skitzki, MD, Myron S. Czuczman, MD, Francisco J. Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2012) 120 (21): 61.
https://doi.org/10.1182/blood.V120.21.61.61
Published: 2012